Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 77

1.

Therapeutic potency of bee pollen against biochemical autistic features induced through acute and sub-acute neurotoxicity of orally administered propionic acid.

Al-Salem HS, Bhat RS, Al-Ayadhi L, El-Ansary A.

BMC Complement Altern Med. 2016 Apr 23;16(1):120. doi: 10.1186/s12906-016-1099-8.

2.

Neurotoxic syndrome induced by clomipramine plus risperidone in a patient with autistic spectrum disorder: serotonin or neuroleptic malignant syndrome?

Nikolaou KN, Gournellis R, Michopoulos I, Dervenoulas G, Christodoulou C, Douzenis A.

Ann Gen Psychiatry. 2015 Nov 14;14:38. doi: 10.1186/s12991-015-0073-z. eCollection 2015.

3.

A study of blood serotonin and serotonin transporter promoter variant (5-HTTLPR) polymorphism in Egyptian autistic children.

Meguid NA, Gebril OH, Khalil RO.

Adv Biomed Res. 2015 May 11;4:94. doi: 10.4103/2277-9175.156658. eCollection 2015.

4.

Protective and restorative potency of Vitamin D on persistent biochemical autistic features induced in propionic acid-intoxicated rat pups.

Alfawaz HA, Bhat RS, Al-Ayadhi L, El-Ansary AK.

BMC Complement Altern Med. 2014 Oct 25;14:416. doi: 10.1186/1472-6882-14-416.

5.

Stereotypic behavior in nonhuman primates as a model for the human condition.

Lutz CK.

ILAR J. 2014;55(2):284-96. doi: 10.1093/ilar/ilu016. Review.

6.

Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion.

Daly E, Ecker C, Hallahan B, Deeley Q, Craig M, Murphy C, Johnston P, Spain D, Gillan N, Gudbrandsen M, Brammer M, Giampietro V, Lamar M, Page L, Toal F, Schmitz N, Cleare A, Robertson D, Rubia K, Murphy DG.

Brain. 2014 Sep;137(Pt 9):2600-10. doi: 10.1093/brain/awu178. Epub 2014 Jul 28.

7.

Fluoxetine for Autistic Behaviors (FAB trial): study protocol for a randomized controlled trial in children and adolescents with autism.

Mouti A, Reddihough D, Marraffa C, Hazell P, Wray J, Lee K, Kohn M.

Trials. 2014 Jun 16;15:230. doi: 10.1186/1745-6215-15-230.

8.

Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice.

Amodeo DA, Jones JH, Sweeney JA, Ragozzino ME.

Autism Res. 2014 Oct;7(5):555-67. doi: 10.1002/aur.1395. Epub 2014 Jun 3.

9.
10.

Autism associated gene, engrailed2, and flanking gene levels are altered in post-mortem cerebellum.

Choi J, Ababon MR, Soliman M, Lin Y, Brzustowicz LM, Matteson PG, Millonig JH.

PLoS One. 2014 Feb 10;9(2):e87208. doi: 10.1371/journal.pone.0087208. eCollection 2014.

11.

Inverse Effect of Fluoxetine on Medial Prefrontal Cortex Activation During Reward Reversal in ADHD and Autism.

Chantiluke K, Barrett N, Giampietro V, Brammer M, Simmons A, Murphy DG, Rubia K.

Cereb Cortex. 2015 Jul;25(7):1757-70. doi: 10.1093/cercor/bht365. Epub 2014 Jan 22.

12.

Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study.

Humble MB, Uvnäs-Moberg K, Engström I, Bejerot S.

BMC Psychiatry. 2013 Dec 23;13:344. doi: 10.1186/1471-244X-13-344.

13.

Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives.

Tordjman S, Najjar I, Bellissant E, Anderson GM, Barburoth M, Cohen D, Jaafari N, Schischmanoff O, Fagard R, Lagdas E, Kermarrec S, Ribardiere S, Botbol M, Fougerou C, Bronsard G, Vernay-Leconte J.

Int J Mol Sci. 2013 Oct 14;14(10):20508-42. doi: 10.3390/ijms141020508. Review.

14.

Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.

King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D.

JAMA Pediatr. 2013 Nov;167(11):1045-52. doi: 10.1001/jamapediatrics.2013.2698.

15.

Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin.

Dölen G, Darvishzadeh A, Huang KW, Malenka RC.

Nature. 2013 Sep 12;501(7466):179-84. doi: 10.1038/nature12518.

16.

Parental broader autism subphenotypes in ASD affected families: relationship to gender, child's symptoms, SSRI treatment, and platelet serotonin.

Levin-Decanini T, Maltman N, Francis SM, Guter S, Anderson GM, Cook EH, Jacob S.

Autism Res. 2013 Dec;6(6):621-30. doi: 10.1002/aur.1322. Epub 2013 Aug 16.

17.

The BOLD signal and neurovascular coupling in autism.

Reynell C, Harris JJ.

Dev Cogn Neurosci. 2013 Oct;6:72-9. doi: 10.1016/j.dcn.2013.07.003. Epub 2013 Jul 12.

18.

Reduced serotonin receptor subtypes in a limbic and a neocortical region in autism.

Oblak A, Gibbs TT, Blatt GJ.

Autism Res. 2013 Dec;6(6):571-83. doi: 10.1002/aur.1317. Epub 2013 Jul 24.

19.

Cognitive abnormalities and hippocampal alterations in monoamine oxidase A and B knockout mice.

Singh C, Bortolato M, Bali N, Godar SC, Scott AL, Chen K, Thompson RF, Shih JC.

Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12816-21. doi: 10.1073/pnas.1308037110. Epub 2013 Jul 15.

20.

Association of maternal exposure to childhood abuse with elevated risk for autism in offspring.

Roberts AL, Lyall K, Rich-Edwards JW, Ascherio A, Weisskopf MG.

JAMA Psychiatry. 2013 May;70(5):508-15. doi: 10.1001/jamapsychiatry.2013.447.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk